ARVEE Stock Overview
Manufactures and sells various specialized chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Arvee Laboratories (India) Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹178.12 |
| 52 Week High | ₹315.00 |
| 52 Week Low | ₹117.05 |
| Beta | 0.59 |
| 1 Month Change | 11.52% |
| 3 Month Change | -1.86% |
| 1 Year Change | -2.27% |
| 3 Year Change | 111.67% |
| 5 Year Change | n/a |
| Change since IPO | 469.98% |
Recent News & Updates
Recent updates
Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Popularity With Investors Under Threat As Stock Sinks 25%
Nov 21
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Shareholder Returns
| ARVEE | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -17.2% | -2.5% | -2.1% |
| 1Y | -2.3% | 8.5% | 22.5% |
Return vs Industry: ARVEE underperformed the Indian Chemicals industry which returned 8.5% over the past year.
Return vs Market: ARVEE underperformed the Indian Market which returned 22.5% over the past year.
Price Volatility
| ARVEE volatility | |
|---|---|
| ARVEE Average Weekly Movement | 9.7% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ARVEE's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: ARVEE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 65 | Shalin Patel | arveelabs.com |
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India and internationally. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid.
Arvee Laboratories (India) Ltd. Fundamentals Summary
| ARVEE fundamental statistics | |
|---|---|
| Market cap | ₹1.96b |
| Earnings (TTM) | ₹22.77m |
| Revenue (TTM) | ₹369.67m |
86.2x
P/E Ratio5.3x
P/S RatioIs ARVEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARVEE income statement (TTM) | |
|---|---|
| Revenue | ₹369.67m |
| Cost of Revenue | ₹191.73m |
| Gross Profit | ₹177.94m |
| Other Expenses | ₹155.17m |
| Earnings | ₹22.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.07 |
| Gross Margin | 48.14% |
| Net Profit Margin | 6.16% |
| Debt/Equity Ratio | 3.2% |
How did ARVEE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 02:10 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arvee Laboratories (India) Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|